Cargando…
Efficacy of Albis for the Prevention of Gastric Mucosal Injury Concomitant with the Use of Low-Dose Aspirin: A Prospective, Randomized, Placebo-Controlled Study
BACKGROUND/AIMS: Long-term use of aspirin can be a risk factor of peptic ulcer diseases. The aim of this study was to evaluate the efficacy of Albis (Daewoong Pharmaceutical Co., Ltd.) for the prevention of gastric mucosal injury caused by aspirin. METHODS: Aspirin users were enrolled and randomized...
Autores principales: | Kim, Sang Gyun, Kim, Nayoung, Shin, Sung Kwan, Sung, In Kyung, Hong, Su Jin, Park, Hyo-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Gastrointestinal Endoscopy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398368/ https://www.ncbi.nlm.nih.gov/pubmed/27196736 http://dx.doi.org/10.5946/ce.2016.031 |
Ejemplares similares
-
In albis : poemas, 1979-1990 /
por: Magaña, Gabriel, 1944- -
Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy
por: Song, Ji Hyun, et al.
Publicado: (2017) -
Continuous Use of Thienopyridine May Be as Safe as Low-Dose Aspirin in Endoscopic Resection of Gastric Tumors
por: Oh, Sooyeon, et al.
Publicado: (2018) -
Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
por: Kim, Tae Hyun, et al.
Publicado: (2022) -
Low‐dose aspirin‐induced gastric mucosal injury after Fontan surgery in an adolescent
por: Kakiuchi, Toshihiko, et al.
Publicado: (2021)